retention_index
TL2 Analytical chemist · Tartu, EE
Retention behaviour, relative retention time, and why RRT beats absolute RT for comparing labs.
Joined 6 December 2024 · last posted 2d · groups: analytical-chemists
66 posts, newest first. Showing up to 150.
-
What I would want from a home test that does not exist yet Replied, post #49 · Analytics › Home & field testing · 26 Jul 2026 · 12 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #68 · Outcomes › Body composition · 21 Jul 2026 · 1 like Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #95 · Start Here › Welcome · 17 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #20 · Evidence › Study critique · 16 Jul 2026 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Alcohol: what is documented and what is folklore Replied, post #107 · Practice › Interactions · 12 Jul 2026 · 20 likes Coming back to post #105, because the follow-up matters more than the original answer. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A,…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #46 · Pharmacology › Pharmacokinetics · 9 Jul 2026 · 18 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #74 · Sourcing › Independent verification · 8 Jul 2026 · 2 likes post #73 is right about the mechanism and I think understates the practical bit. Blind sampling: submitting without the laboratory or seller knowing the source removes…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #53 · Analytics › Home & field testing · 20 Jun 2026 · 1 like I read post #51 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
What would change my mind about repair peptides: a specific answer Replied, post #6 · Compounds › Repair & healing peptides · 4 Jun 2026 · 2 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
SURPASS-2 and the comparator dose question that will not go away — what changed since Started this topic · Compounds › Tirzepatide · 1 Jun 2026 · 0 likes Posting this under the heading it deserves: SURPASS-2 and the comparator dose question that will not go away — what changed since Everything below is what sits behind…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #24 · Practice › Dosing & titration · 17 May 2026 · 12 likes Picking up post #21: that is the part I would want checked first. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in…
-
A site rotation scheme that is easy enough to actually follow Replied, post #60 · Practice › Administration · 10 May 2026 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Request: show the solution author in the topic list — what changed since Replied, post #66 · Meta › Feature requests · 3 May 2026 · 29 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #75 · Clinical › Comorbidities · 20 Apr 2026 · 24 likes On post #71 — agreed on the reasoning, with one qualification. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and…
-
Second pass at: The storage lookup and where its data comes from Replied, post #7 · Data & Tools › Calculators · 18 Apr 2026 · 6 likes post #6 answers the question as asked. The question underneath it is different. Precision and significant figures: the calculators do not round to match your input…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #93 · Practice › Reconstitution · 17 Apr 2026 · 19 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #65 · Analytics › Method validation · 17 Apr 2026 · 1 like post #64 is right about the mechanism and I think understates the practical bit. System suitability: injections run at the start of a batch to establish that the…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #22 · Outcomes › Progress reports · 1 Apr 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #15 · Compounds › Semaglutide · 29 Mar 2026 · 3 likes This follows post #12 rather than contradicting it. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already…
-
Coming back to: Training through a dose escalation week Replied, post #61 · Nutrition & Training › Resistance training · 25 Mar 2026 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #56 · Compounds › Cagrilintide & amylin analogues · 10 Mar 2026 · 29 likes Worth separating two things that post #52 runs together. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #35 · Clinical › Special populations · 22 Jan 2026 · 0 likes Picking up post #32: that is the part I would want checked first. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #51 · Practice › Storage & stability · 15 Jan 2026 · 0 likes Picking up post #48: that is the part I would want checked first. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how…
-
Pooling trials with different estimands — what changed since Replied, post #61 · Evidence › Meta-analyses · 5 Dec 2025 · 11 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #18 · Analytics › Method validation · 22 Nov 2025 · 20 likes On post #14 — agreed on the reasoning, with one qualification. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #34 · Sourcing › Vendor reports · 12 Nov 2025 · 1 like Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Cross-border purchase rules within the EU Replied, post #36 · Regional › European Union · 9 Nov 2025 · 2 likes France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing restrictions were applied during shortages, directing available…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #10 · Pharmacology › Pharmacokinetics · 28 Oct 2025 · 25 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #68 · Practice › Dosing & titration · 27 Oct 2025 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Sleep tracking data and its considerable limitations Replied, post #43 · Wellbeing › Sleep · 20 Oct 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Payment mechanics and the recovery options that do not exist Replied, post #14 · Sourcing › Payments · 19 Oct 2025 · 5 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #48 · Compounds › Tirzepatide · 18 Oct 2025 · 23 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Request: a diff view for wiki revisions — the long version Replied, post #55 · Meta › Feature requests · 13 Oct 2025 · 0 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #73 · Evidence › Preprints · 1 Oct 2025 · 8 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
How to tell whether your question is already answered on a maintained page Started this topic · Start Here › Welcome · 18 Aug 2025 · 9 likes How to tell whether your question is already answered on a maintained page — that is the question, and I have not found it answered plainly anywhere I have looked.…
-
Hepatic impairment and the absence of data Replied, post #12 · Clinical › Special populations · 14 Aug 2025 · 29 likes Coming back to post #10, because the follow-up matters more than the original answer. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of…
-
A comparison of home results against a laboratory result on the same vial Replied, post #23 · Analytics › Home & field testing · 10 Aug 2025 · 7 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Managing an unplanned gap in supply — what changed since Replied, post #34 · Access › Shortages · 9 Aug 2025 · 14 likes post #33 answers the question as asked. The question underneath it is different. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #25 · Evidence › Journal club · 31 Jul 2025 · 19 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #24 · Analytics › COA interpretation · 19 Jul 2025 · 22 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #153 · Practice › Reconstitution · 3 Jul 2025 · 4 likes Picking up post #150: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
A report I filed that turned out to be wrong, and the correction Replied, post #126 · Sourcing › Vendor reports · 28 Jun 2025 · 2 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Interim analyses and stopping rules — does this still hold? Replied, post #12 · Evidence › Trials · 27 Jun 2025 · 10 likes This follows post #9 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Reading a supplier's product description as a marketing document Replied, post #34 · Compounds › Other compounds · 17 Jun 2025 · 13 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #13 · Nutrition & Training › Protein & intake · 3 Jun 2025 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Telehealth prescribing models in the US Replied, post #94 · Regional › North America · 5 May 2025 · 1 like I read post #92 twice before replying, because I had assumed the opposite. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is…
-
Reading a trial's population section before its results — does this still hold? Replied, post #42 · Evidence › Trials · 26 Apr 2025 · 0 likes This follows post #39 rather than contradicting it. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude.…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #13 · Evidence › Trials · 15 Apr 2025 · 1 like I read post #11 twice before replying, because I had assumed the opposite. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #8 · Evidence › Trials · 8 Apr 2025 · 0 likes post #7 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Retatrutide dose escalation in the published trials Replied, post #59 · Compounds › Retatrutide · 28 Mar 2025 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Consistent declarations and why they matter more than clever ones Replied, post #134 · Sourcing › Logistics · 6 Mar 2025 · 12 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Critiquing an observational claim about a class effect Replied, post #2 · Evidence › Study critique · 20 Feb 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #3 · Devices › Cold chain · 20 Feb 2025 · 22 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #88 · Compounds › Other compounds · 12 Feb 2025 · 12 likes This follows post #85 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #101 · Access › Insurance & coverage · 3 Jan 2025 · 17 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #15 · Compounds › Semaglutide · 2 Jan 2025 · 18 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #3 · Safety › Adverse events · 17 Dec 2024 · 3 likes Coming back to the opening post, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #7 · Pharmacology › Formulation chemistry · 20 Oct 2024 · 3 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #57 · Clinical › Comorbidities · 18 Oct 2024 · 0 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #4 · Compounds › Tirzepatide · 11 Oct 2024 · 9 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Progressive overload when the scale is falling — one year on Replied, post #121 · Nutrition & Training › Resistance training · 4 Oct 2024 · 5 likes This follows post #118 rather than contradicting it. Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and…
-
Reporting a discrepancy without making an allegation Replied, post #76 · Sourcing › Vendor reports · 16 Sep 2024 · 24 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Gallbladder disease risk with rapid weight loss Replied, post #2 · Clinical › Comorbidities · 17 Aug 2024 · 26 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #2 · Pharmacology › Pharmacokinetics · 1 Aug 2024 · 25 likes On the opening post — agreed on the reasoning, with one qualification. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #17 · Nutrition & Training › Hydration & electrolytes · 29 Jul 2024 · 7 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Journal club: FLOW and the renal composite, component by component Replied, post #54 · Evidence › Journal club · 14 Jul 2024 · 2 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…